Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference
Twist Bioscience (NASDAQ: TWST), a mid-cap life sciences company, has announced that CEO and co-founder Emily M. Leproust, Ph.D. will deliver a presentation at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for January 13, 2025, at 5:15 p.m. Pacific Time in San Francisco, California.
The event will be accessible via webcast through the company's investor relations website's 'Investor Calendar' section. Following the live presentation, a replay will remain available for 30 days.
Twist Bioscience (NASDAQ: TWST), un'azienda di scienze della vita di medie dimensioni, ha annunciato che il CEO e co-fondatore Emily M. Leproust, Ph.D. terrà una presentazione alla 43ª Conferenza Annuale J.P. Morgan sulla Salute. La presentazione è programmata per 13 gennaio 2025, alle 17:15 ora del Pacifico a San Francisco, California.
L'evento sarà accessibile tramite webcast nella sezione 'Calendario degli Investitori' del sito web delle relazioni con gli investitori dell'azienda. Dopo la presentazione dal vivo, una registrazione sarà disponibile per 30 giorni.
Twist Bioscience (NASDAQ: TWST), una empresa de ciencias de la vida de mediana capitalización, ha anunciado que la CEO y cofundadora Emily M. Leproust, Ph.D. dará una presentación en la 43ª Conferencia Anual de Atención Médica J.P. Morgan. La presentación está programada para 13 de enero de 2025, a las 5:15 p.m. hora del Pacífico en San Francisco, California.
El evento será accesible a través de una transmisión web en la sección 'Calendario de Inversores' del sitio web de relaciones con inversores de la empresa. Después de la presentación en vivo, una repetición estará disponible durante 30 días.
Twist Bioscience (NASDAQ: TWST)는 중형 생명 과학 회사로, CEO이자 공동 창립자인 Emily M. Leproust, Ph.D.가 제43회 JP모건 헬스케어 컨퍼런스에서 발표할 것이라고 발표했습니다. 발표는 2025년 1월 13일, 태평양 표준시 오후 5시 15분에 샌프란시스코, 캘리포니아에서 예정되어 있습니다.
이 행사는 회사의 투자자 관계 웹사이트 '투자자 달력' 섹션을 통해 웹캐스트를 통해 접근할 수 있습니다. 라이브 발표 후, 다시보기는 30일 동안 제공됩니다.
Twist Bioscience (NASDAQ: TWST), une entreprise de biotechnologie de taille moyenne, a annoncé que la PDG et co-fondatrice Emily M. Leproust, Ph.D. fera une présentation lors de la 43e Conférence Annuelle J.P. Morgan sur la Santé. La présentation est prévue pour le 13 janvier 2025, à 17h15, heure du Pacifique, à San Francisco, Californie.
L'événement sera accessible par webinaire via la section 'Calendrier des Investisseurs' du site web des relations investisseurs de l'entreprise. Après la présentation en direct, un enregistrement sera disponible pendant 30 jours.
Twist Bioscience (NASDAQ: TWST), ein mittelständisches Unternehmen im Bereich der Lebenswissenschaften, hat bekannt gegeben, dass die CEO und Mitbegründerin Emily M. Leproust, Ph.D. eine Präsentation auf der 43. J.P. Morgan Healthcare Conference halten wird. Die Präsentation ist für 13. Januar 2025, um 17:15 Uhr pazifischer Zeit in San Francisco, Kalifornien, angesetzt.
Die Veranstaltung wird über einen Webcast über die 'Investor Calendar'-Sektion der Investor Relations-Website des Unternehmens zugänglich sein. Nach der Live-Präsentation wird eine Aufzeichnung für 30 Tage verfügbar sein.
- None.
- None.
The presentation will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the presentation will be archived for a period of 30 days following the conclusion of the live events.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Follow us on LinkedIn | X | YouTube | Instagram
View source version on businesswire.com: https://www.businesswire.com/news/home/20241219026063/en/
For Investors:
Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com
For Media:
Amanda Houlihan
Communications Manager
774-265-5334
ahoulihan@twistbioscience.com
Source: Twist Bioscience Corporation
FAQ
When is Twist Bioscience (TWST) presenting at the J.P. Morgan Healthcare Conference 2025?
How can investors watch Twist Bioscience's (TWST) J.P. Morgan Healthcare Conference presentation?
How long will the replay of Twist Bioscience's (TWST) J.P. Morgan presentation be available?
Who will represent Twist Bioscience (TWST) at the 2025 J.P. Morgan Healthcare Conference?
